1. Known hypersensitivity to meloxicam

2. Cross hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs

3. Symptoms of asthma, rhinitis, angioneurotic edema, or urticaria following the administration of aspirin or other NSAIDs

4. Active peptic ulceration

5. Severe hepatic failure.

6. Non-dialysed severe renal insufficiency

7. Children and adolescents aged 15 years or less

8. Pregnancy or breastfeeding

Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study